Pesquisas alternativas:
small companies » small communities (Expandir a Pesquisa)
companies phase » companies case (Expandir a Pesquisa), companies past (Expandir a Pesquisa), companies choose (Expandir a Pesquisa)
nay clamp » dnan clamp (Expandir a Pesquisa), a clamp (Expandir a Pesquisa), dna clamp (Expandir a Pesquisa)
can ngos » can ngoc (Expandir a Pesquisa), can non (Expandir a Pesquisa), can now (Expandir a Pesquisa)
clamp j » clamp _ (Expandir a Pesquisa)
j nay » j nagy (Expandir a Pesquisa), _ nay (Expandir a Pesquisa)
j new » a new (Expandir a Pesquisa), _ new (Expandir a Pesquisa), 2 new (Expandir a Pesquisa)
small companies » small communities (Expandir a Pesquisa)
companies phase » companies case (Expandir a Pesquisa), companies past (Expandir a Pesquisa), companies choose (Expandir a Pesquisa)
nay clamp » dnan clamp (Expandir a Pesquisa), a clamp (Expandir a Pesquisa), dna clamp (Expandir a Pesquisa)
can ngos » can ngoc (Expandir a Pesquisa), can non (Expandir a Pesquisa), can now (Expandir a Pesquisa)
clamp j » clamp _ (Expandir a Pesquisa)
j nay » j nagy (Expandir a Pesquisa), _ nay (Expandir a Pesquisa)
j new » a new (Expandir a Pesquisa), _ new (Expandir a Pesquisa), 2 new (Expandir a Pesquisa)
1
“... by regulatory requirements, that must be met to bring a new drug to market, such as completion of preclinical...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
2
A pooled analysis of advanced nonsquamous non-small cell lung cancer patients with stable treated...
Por Gubens, Matthew A., Chuang, Jody C., Akerley, Wallace, Langer, Corey J., Clément-Duchêne, Christelle, San Pedro-Salcedo, Melanie, Colevas, A. Dimitrios, Dragnev, Konstantin, Socinski, Mark A., Wakelee, Heather A.
Publicado no J Thorac Dis (2018)
“...BACKGROUND: Brain metastases are a common complication of advanced non-small cell lung cancer...”Publicado no J Thorac Dis (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
3
“...Surgery is regarded as the primary treatment modality for early stage non-small cell lung cancer...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
4
“... for non-small cell lung cancer (NSCLC) has emerged as a powerful treatment option for advanced lung cancer...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
5
Por Winter, Hauke, van den Engel, Natasja K., Rusan, Margareta, Schupp, Nina, Poehlein, Christian H., Hu, Hong-Ming, Hatz, Rudolf A., Urba, Walter J., Jauch, Karl-Walter, Fox, Bernard A., Rüttinger, Dominik
Publicado em 2011
“...Non-small cell lung cancer constitutes about 85% of all newly diagnosed cases of lung cancer...”Publicado em 2011
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
6
Por Nishio, Makoto, Hida, Toyoaki, Atagi, Shinji, Sakai, Hiroshi, Nakagawa, Kazuhiko, Takahashi, Toshiaki, Nogami, Naoyuki, Saka, Hideo, Takenoyama, Mitsuhiro, Maemondo, Makoto, Ohe, Yuichiro, Nokihara, Hiroshi, Hirashima, Tomonori, Tanaka, Hiroshi, Fujita, Shiro, Takeda, Koji, Goto, Koichi, Satouchi, Miyako, Isobe, Hiroshi, Minato, Koichi, Sumiyoshi, Naoki, Tamura, Tomohide
Publicado no ESMO Open (2017)
“... monoclonal antibody approved for the treatment of non-small cell lung cancer (NSCLC). The aim of this study...”Publicado no ESMO Open (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
7
Por Zhao, Jun, Zhuo, Minglei, Wang, Zhijie, Duan, Jianchun, Wang, Yuyan, Wang, Shuhang, An, Tongtong, Wu, Meina, Wang, Jie
Publicado no Chin J Cancer Res (2016)
“... with docetaxel in advanced non-small-cell lung cancer (NSCLC) patients who have failed to respond to prior first...”Publicado no Chin J Cancer Res (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
8
Por Dragnev, Konstantin H., Whyman, Jeremy D., Hahn, Cynthia K., Kebbekus, Peter E., Kokko, Sarah F., Bhatt, Sunil M., Rigas, James R.
Publicado no J Thorac Dis (2018)
“... with chemotherapy. This phase I/II study evaluates the tolerability and activity of a rexinoid, bexarotene, combined...”Publicado no J Thorac Dis (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
9
“...Stem bulge RNAs (sbRNAs) are a family of small non-coding stem-loop RNAs present in Caenorhabditis...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
10
“... of care for stage IV EGFR mutated non-small cell lung cancer (NSCLC) patients initiating first-line...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
11
Por Alain A. Vertès
Publicado em 2012-07-01
Assuntos:
“...non-zero sum game...”Publicado em 2012-07-01
Obter o texto integral
Artigo
12
Por Ridenour, Dennis A., McLennan, Rebecca, Teddy, Jessica M., Semerad, Craig L., Haug, Jeffrey S., Kulesa, Paul M.
Publicado em 2014
“... events and how cell cycle is related to phases of migration remain unclear. Here, we examined...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
13
“...BACKGROUND: ASA404 (5,6-dimethylxanthenone-4-acetic acid) is a small-molecule, flavonoid tumor...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
14
“...BACKGROUND: In advanced non-small cell lung cancer (NSCLC), the increasing number of active...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
15
“... the two treatment arms. Thus platinum-based chemotherapy combined with cetuximab represents a new...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
16
Por Kurokawa, Y, Boku, N, Yamaguchi, T, Ohtsu, A, Mizusawa, J, Nakamura, K, Fukuda, H
Publicado no ESMO Open (2016)
“... phase III trials. However, few studies have evaluated inter-institutional heterogeneity in randomised...”Publicado no ESMO Open (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
17
18
Por Hu, Xingsheng, Wang, Lin, Lin, Lin, Han, Xiaohong, Dou, Guifang, Meng, Zhiyun, Shi, Yuankai
Publicado no Chin J Cancer Res (2016)
“..., in combination with paclitaxel and carboplatin in patients with advanced non-small cell lung cancer (NSCLC...”Publicado no Chin J Cancer Res (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo